Autek China Inc - Asset Resilience Ratio

Latest as of September 2025: 20.10%

Autek China Inc (300595) has an Asset Resilience Ratio of 20.10% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Autek China Inc for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.29 Billion
≈ $188.98 Million USD Cash + Short-term Investments

Total Assets

CN¥6.42 Billion
≈ $940.14 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Autek China Inc's Asset Resilience Ratio has changed over time. See 300595 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Autek China Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300595 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.29 Billion 20.1%
Total Liquid Assets CN¥1.29 Billion 20.10%

Asset Resilience Insights

  • Good Liquidity Position: Autek China Inc maintains a healthy 20.10% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Autek China Inc Industry Peers by Asset Resilience Ratio

Compare Autek China Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
Medical Instruments & Supplies 9.08%
Vizionfocus Inc.
TW:4771
Medical Instruments & Supplies 5.07%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.23%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 43.09%

Annual Asset Resilience Ratio for Autek China Inc (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Autek China Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 20.79% CN¥1.25 Billion
≈ $183.47 Million
CN¥6.03 Billion
≈ $882.51 Million
-17.57pp
2023-12-31 38.36% CN¥2.12 Billion
≈ $309.75 Million
CN¥5.52 Billion
≈ $807.59 Million
+12.19pp
2022-12-31 26.17% CN¥1.34 Billion
≈ $195.99 Million
CN¥5.12 Billion
≈ $749.00 Million
+2.66pp
2021-12-31 23.51% CN¥698.85 Million
≈ $102.26 Million
CN¥2.97 Billion
≈ $434.96 Million
-20.77pp
2020-12-31 44.28% CN¥979.91 Million
≈ $143.39 Million
CN¥2.21 Billion
≈ $323.82 Million
+29.13pp
2019-12-31 15.15% CN¥243.33 Million
≈ $35.61 Million
CN¥1.61 Billion
≈ $235.01 Million
-16.97pp
2012-12-31 32.12% CN¥37.30 Million
≈ $5.46 Million
CN¥116.13 Million
≈ $16.99 Million
--
pp = percentage points

About Autek China Inc

SHE:300595 China Medical Instruments & Supplies
Market Cap
$1.89 Billion
CN¥12.91 Billion CNY
Market Cap Rank
#6483 Global
#1467 in China
Share Price
CN¥14.42
Change (1 day)
+0.91%
52-Week Range
CN¥13.78 - CN¥19.38
All Time High
CN¥106.29
About

Autek China Inc. engages in the research and development, production, and sale of hard contact lens products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic … Read more